Armgo Pharma
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 425-0000Website
www.armgo.comRevenue
<$5 MillionIndustry
About Armgo Pharma
RyCarma Therapeutics is a clinical-stage company focused on developing a novel class of therapeutics known as Rycals, targeting serious diseases linked to ryanodine receptors. Their lead program aims to treat ryanodine receptor 1-related myopathies (RYR1-RM), a rare but significant type of congenital myopathy caused by calcium channel dysfunction. The company's innovative approach seeks to address the root causes of these muscle diseases, offering potential improvements in muscle strength and functional outcomes. RyCarma Therapeutics is dedicated to addressing high unmet medical needs in the field of muscle disorders.Explore more
Armgo Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Armgo Pharma
Compare insights from companies similar to Armgo Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Armgo Pharma Tech Stack
A closer look at the technologies used by Armgo Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Armgo Pharma
Sign Up For FreeTo access detailed company insights
RyCarma Therapeutics is a clinical-stage company focused on developing a novel class of therapeutics known as Rycals, targeting serious diseases linked to ryanodine receptors. Their lead program aims to treat ryanodine receptor 1-related myopathies (RYR1-RM), a rare but significant type of congenital myopathy caused by calcium channel dysfunction.... Read More
